Tourism suffers again on the stock market due to delays in vaccines against the coronavirus
Stocks in the tourism sector suffered another setback in the stock market after Johnson & Johnson temporarily suspended trials on the coronavirus vaccine and Eli Lilly stopped trials of its experimental antibody-based treatment against Covid-19.
The shares of the Meliá hotel group plummeted around 6% on the Madrid Stock Exchange and have already accumulated losses close to 60% of their value so far in 2020.
The delicate situation that the group is experiencing due to the mobility restrictions that it has been caused by the coronavirus pandemic has led Deutsche Bank to lower its recommendation, from hold to sell.
Source: Admiral Markets MetaTrader 5. Meliá CFD daily chart. Data range: from June 6, 2019, to October 14, 2020. Prepared on October 14, 2020, at 12:10 p.m. Keep in mind that past returns do not guarantee future returns.
As we see in the graph, Meliá has not managed to recover from the general collapse at the end of February when the first mobility restrictions were established throughout Europe. The group, beyond the general crisis that it is going through in 2020, has not managed to be a profitable and stable value on the stock market. In the last five years it only closed 2017 positively.
Other stocks in the tourism sector that fell today on the stock market due to the delays in vaccines are:
- InterContinental Hotels Group (-1.28%)
- French Accor (-0.40%)
In the US session:
- Hilton Worldwide Holdings posted a 2.97% drop
- Marriott International 2.45%.
Did you know that with Admiral Markets UK Ltd you can invest in all of these companies? You can do this through Contracts for Difference (CFD), which allows you to speculate on price movements, both up and down. Click on the following banner to open a real trading account and start trading:
INFORMATION ON ANALYTICAL MATERIALS:
The data provided provides additional information on all analyzes, estimates, forecasts, forecasts, market reviews, weekly outlooks or other evaluations or similar information (hereinafter "Analysis") published on the Admiral Markets website. Before making any investment decisions, pay close attention to the following:
1. This is a marketing communication. The content is posted for informational purposes only and should not be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and is not subject to any prohibition on pre-dissemination of investment research.
2. Each investment decision is made by each client alone, while Admiral Markets UK Ltd (Admiral Markets) will not be liable for any loss or damage arising from such a decision, whether based on content or not.
3. In order to protect the interests of our clients and the objectivity of the Analysis, Admiral Markets has established relevant internal procedures for the prevention and management of conflicts of interest.
4. The analysis is prepared by an independent analyst, Carolina Caro, SEO implementer (hereinafter "Author") based on personal estimates.
5. While all reasonable efforts are made to ensure that all sources of content are reliable and that all information is presented, as much as possible, in an understandable, timely, accurate, and complete manner, Admiral Markets does not guarantee accuracy. or integrity of any information contained in the Analysis.
6. Any past performance or modelling of the financial instruments indicated in the content should not be construed as an express or implied promise, guarantee, or implication of Admiral Markets for any future performance. The value of the financial instrument may rise and fall, and the preservation of the asset's value is not guaranteed.
7. Leveraged products (including contracts for difference) are speculative in nature and may generate profit or loss. Before you start trading, make sure you fully understand the risks.